Surgery Partners, Inc. Reports Impressive Growth and 2025 Goals
Surgery Partners, Inc. Financial Performance Review
Surgery Partners, Inc. (NASDAQ: SGRY), a prominent owner and operator of outpatient surgical facilities, recently released its financial results for the fourth quarter and the full year of 2024. The company showcased impressive growth, continuing its trend of expanding operational success.
Highlights from 2024 Results
During the fourth quarter, Surgery Partners experienced a revenue increase of 17.5%, amounting to an impressive $864.4 million compared to the previous year. For the entire year, revenue rose by 13.5%, totaling $3.1 billion, underlining the sustained demand for its surgical services.
The same-facility revenue also followed suit, climbing 5.6% in Q4 and 8.0% across the year. This increase reflects Surgery Partners' ability to attract more cases, as evidenced by a 5.1% rise in same-facility cases during the fourth quarter.
Long-Term Adjustments and Fiscal Management
Despite the robust revenue growth, the company reported a net loss of $108.5 million in Q4 and $168.1 million for the full year. This loss was impacted by a non-cash valuation allowance against deferred tax assets, resulting from technical accounting mandates. Surgery Partners plans to offset federal income taxes through its net operating loss carryforwards until 2029, which positions the company well for future profitability.
Adjusted EBITDA and Margin Growth
Adjusted EBITDA for the fourth quarter surged by 15.1% to $163.8 million, escalating to a total of $508.2 million for the year, reflecting an adjustment margin growth by 30 basis points to 16.3%. This improvement indicates a positive trajectory in operational efficiency and profitability.
Looking Ahead: Guidance for 2025
Eric Evans, the Chief Executive Officer, expressed optimism regarding the company’s growth momentum. For 2025, Surgery Partners projects revenues between $3.30 billion and $3.45 billion, alongside an anticipated Adjusted EBITDA in the range of $555 million to $565 million. This forecast is predicated on strategic expansions and operational enhancements intended to deliver exceptional value to both patients and healthcare plans.
Strategic Initiatives and Facility Expansions
Throughout 2024, Surgery Partners invested nearly $400 million on acquisitions and opened eight new facilities. These initiatives are pivotal as the company aims to broaden its network, ensuring high-quality surgical care across multiple states. The operational advancements underscore the company’s commitment to enriching patient experiences and enhancing service accessibility.
Strong Liquidity Position
Surgery Partners ended the year with a strong liquidity position, boasting over $770 million in liquid assets, empowering the company to pursue further mergers and acquisitions without relying on external capital markets. This robust financial footing instills confidence in Surgery Partners' ability to navigate the evolving healthcare landscape effectively.
Conclusion: A Promising Future
As Surgery Partners continues to evolve and expand, its focus remains on leveraging existing strengths to capitalize on new growth opportunities in the outpatient surgical sector. The company's strategic vision and unwavering commitment to operational excellence position it favorably for sustained success in the coming years. Investors and stakeholders alike can look forward to an exciting journey ahead as Surgery Partners, Inc. embarks on its ambitious 2025 strategy.
Frequently Asked Questions
What are the financial highlights for Surgery Partners, Inc. in 2024?
In 2024, Surgery Partners reported a 17.5% revenue increase in Q4 and a total annual revenue of $3.1 billion, reflecting strong demand for surgical services.
How did Surgery Partners manage its losses?
The reported net losses stemmed mainly from a non-cash valuation allowance against deferred tax assets, with expectations of offsetting federal taxes until 2029.
What is the outlook for Surgery Partners in 2025?
The company projects revenues between $3.30 billion and $3.45 billion, with Adjusted EBITDA expected to be between $555 million and $565 million.
How much was invested in acquisitions by Surgery Partners in 2024?
Surgery Partners deployed nearly $400 million towards acquisitions to expand its network and service offerings.
What does the liquidity position of Surgery Partners look like?
As of year-end 2024, Surgery Partners maintained over $770 million in liquidity, allowing continued investment in growth without external financing.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
